¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°©»ó¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø, #¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø, #°©»ó¼º±â´ÉÀúÇÏÁõ, #¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ, #°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø, #°©»ó¼º±â´ÉÀúÇÏÁõÇÑÀÇ¿ø, #¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ, #ºÎõ°©»ó¼±ÇÑÀÇ¿ø ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø,,¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø,,°©»ó¼º±â´ÉÀúÇÏÁõ,,¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ,,°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø,,°©»ó¼º±â´ÉÀúÇÏÁõÇÑÀÇ¿ø,,¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ,,ºÎõ°©»ó¼±ÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â°©»ó¼º±â´ÉÀúÇÏÁõ, °©»ó¼±ÇÑÀÇ¿ø, °©»ó¼±È¤, °©»ó¼±Áõ»ó, °©»ó¼±¿ä¿Àµå, °©»ó¼±±â´ÉÇ×ÁøÁõ, °©»ó¼±Å¬¸®´Ð, °©»ó¼±Ä¡·á, °©»ó¼±±â´ÉÀúÇÏÁõÇÑÀÇ¿ø, °©»ó¼±, °©»ó¼±Ç×ÁøÁõ, °©»ó¼±µÎÅë, ¸ñ°©»ó¼±, °©»ó¼±¿ä¿Àµå, °©»ó¼º±â´ÉÀúÇÏÁõ, °©»ó¼±Ã¼ÁßÁõ°¡, °©»ó¼±±â´ÉÀúÇÏÁõÀÓ½Å, °©»ó¼±ºÎÀ½, °©»ó¼±±â´ÉÀúÇÏÁõÀÓ½Å, °©»ó¼±±â´ÉÇ×ÁøÁõÇÑÀÇ¿ø, °©»ó¼±Ä¡·á, °©»ó»ùÀúÇÏÁõ, °©»ó¼±°áÀý, °©»ó¼±È¤Áõ»ó, °©»ó¼±Ã¼ÁßÁõ°¡µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, üÁßÁ¶Àý¿µ¾ç±³À°ÆÐÅ°Áö, ôÃß±â±âµµÀÎ, ¸¶»çÁö, °üÀýôÃߺÀ¾àħ¿ä¹ý, ¾Æ·Î¸¶Å׶óÇÇ, ÃÊÀ½ÆĽɺο­Ä¡·á, ±Ý¿¬Ä§, ÇѹæÀçÈ°, ÀåħÀü±âÀڱؼú, °ñµµ¹ý°Ë»ç, °üÀýº¸È£´ë, ºñ°­·¹ÀÌÀú, °æÇÇÀû¿Ü¼±Á¶»ç¿ä¹ý, sonostim, ÀÚÇϰžàħ, Ư¼öÃß³ª, ¾óÀ½ÆÑ, µµÀοä¹ý, ¼ÒÇÕÇâ¿ø, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² °í¼º±º ¿µÇö¸é, °æ±â ¼º³²½Ã Áß¿ø±¸ ÇÏ´ë¿øµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ´ë¿Üµ¿, °æºÏ ±èõ½Ã ÀÀ¸íµ¿, Ãæ³² È«¼º±º Àå°î¸é, °æ±â µ¿µÎõ½Ã ±¤¾Ïµ¿, °æ³² °í¼º±º ¿µ¿À¸é, ÃæºÏ û¿ø±º ¿À¼ÛÀ¾, ÀüºÏ ÀÍ»ê½Ã ¿©»ê¸é, °æ³² ÇԾȱº Ä¥ºÏ¸é, Ãæ³² ´çÁø½Ã ä¿îµ¿, ¼¼Á¾ ÇѼֵ¿, °æ±â ¾È¼º½Ã »ç°îµ¿, ºÎ»ê ¼­±¸ ¼­´ë½Åµ¿1°¡, ºÎ»ê Áß±¸ ³²Æ÷µ¿2°¡, ºÎ»ê Áß±¸ º¸¼öµ¿1°¡, ÀüºÏ ±èÁ¦½Ã º¹Á×µ¿, ºÎ»ê °­¼­±¸ °­µ¿µ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ È¿ÀÚµ¿3°¡, Ãæ³² °øÁֽà ¿ù¹Ìµ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç9µ¿, °æ±â ±ºÆ÷½Ã »êº»µ¿, ºÎ»ê »çÇϱ¸ ½ÅÆòµ¿, Àü³² ¿©¼ö½Ã µ¹»êÀ¾, °æºÏ ¿µÃµ½Ã ±ÝÈ£À¾, ¿ï»ê ºÏ±¸ È¿¹®µ¿, ÀÎõ ³²µ¿±¸ ¼­Ã¢µ¿, ÃæºÏ ¿µµ¿±º ¸Å°î¸é, ¼¼Á¾ ¹Ý°îµ¿, ¿ï»ê ³²±¸ ¼º¾Ïµ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â °è¾ç±¸, ±¸¿ùµ¿, ÆÈź¸é, ÀÎõ, µ¿Ãᵿ, ¹è°ð½Åµµ½Ã, µµÈ­µ¿, ºñºÀ¸é, û¶ó, »óµ¿, ¿¬Èñµ¿, Á־ȵ¿, °è»êµ¿, ¸¶µµ¸é, °¡Á¤µ¿, ³²¾çÀ¾, µ¿±¸, µ¿ÀÎõ, ¼Ûµµ, ¼Ûµµ½Åµµ½Ã, ¼Û¿ùµ¿, µµ¸²µ¿, ½ÃÈï, ¹è°ð, °ü±³µ¿, ûÇе¿, ¼Û»ê¸é, ¿î¼­µ¿, ½ÃÈ­, °£¼®µ¿, ¿µÁ¾Çϴõµ½Ã, °¡Áµ¿, ´ëºÎµµ, ÀÎõ³íÇöµ¿, ¼Ò·¡Æ÷±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. CATZ B, RUSSELL S. Myxedema, shock and coma. Seven survival cases. Arch Intern Med 1961; 108:407. 2. Sawka AM, Gerstein HC, Marriott MJ, et al. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88:4551. 3. Saravanan P, Simmons DJ, Greenwood R, et al. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90:805. 4. Aronson R, Offman HJ, Joffe RT, Naylor CD. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 1996; 53:842. 5. Duntas LH. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 2010; 95:5180. 6. Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ 2001; 323:891. 7. Hennemann G, Docter R, Visser TJ, et al. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004; 14:271. 8. Blakesley V, Awni W, Locke C, et al. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 2004; 14:191.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°©»ó¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ½ÃÈïÇÑÀÇ¿øÀßÇϴ°÷ Ä¡·á Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û ¼Ûµµ´ÙÀ̾îÆ® ÇÑÀÇ¿ø¿¡¼­
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
112 À§ÀåÀü¹® ÇÑÀÇ¿ø À§Æ°ÇÑÀÇ¿ø 57 22,321 2016-03-07
111 õ¾ÈÇÑÀÇ¿ø ¾î¶»°Ô ¼±ÅÃÇÒ±î¿ä 1 3,595 2016-03-07
110 ºÎÆò·ù¸¶Æ¼½º°üÀý¿° ÇÑÀÇ¿ø¿¡¼­´Â 1 3,357 2016-03-07
109 õõµ¿ À¯¸íÇÑÇÑÀÇ¿ø ãÀ¸½Ã³ª¿ä? 3 11,115 2016-03-07
108 ¾È»ê±³Åë»ç°íÇÑÀÇ¿ø ¸ÆÇÑÀÇ¿ø 0 13,764 2016-03-07
107 ³ë¿ø±¸ÇÑÀÇ¿ø ¸ñÅëÁõ ½ÉÇϸé? 0 4,357 2016-03-07
106 ºÎõ»óµ¿ÇÑÀÇ¿ø Ãßõ 1 19,248 2016-03-07
105 ¾Æ»êÇÑÀÇ¿ø ³­ÀÓÀ¸·Î Èûµå½Å°¡¿ä 0 4,891 2016-03-07
104 ¼ºÀξÆÅäÇÇÇÑÀÇ¿ø ±«·Ó´Ù¸é? 0 4,217 2016-03-07
103 ûÁÖÇÑÀÇ¿ø À¯»êÀ» ¹æÁöÇÏ·Á¸é 0 3,930 2016-03-07
102 ºñ¿°ÇÑÀÇ¿ø Ä¡·á¿Í È¿°ú 1 16,223 2016-03-07
101 È­Á¢¸ùÇÑÀÇ¿ø - ¿©µå¸§ °ü¸® À̺¥Æ® 0 2,960 2015-08-04
100 µ¿¹é¹ÌÁîÇÑÀÇ¿ø - °í°´ ¼º¿ø °¨»ç±â³ä! 1 1,666 2015-08-04
99 º¯ÇÑÀÇ¿ø - 3¡¤3ÇÑ ¿©¸§À̺¥Æ® 0 1,279 2015-07-15
98 È­Á¢¸ùÇÑÀÇ¿ø - ¸ð°ø°¢È­Áõ º¹³¯ À̺¥Æ® 1 2,755 2015-07-15
97 Á¦¼¼ÇÑÀÇ¿ø - ¿©¸§¸ÂÀÌ ³¯¾À ´ÙÀ̾îÆ® 1 1,286 2015-07-15
96 ÀÚ¿¬°úÇÑÀÇ¿ø - ¿©¸§´ëºñ ´ÙÀ̾îÆ® ÆÐÅ°Áö À̺¥Æ® 0 1,538 2015-07-13
95 ÀϸÆÇÑÀÇ¿ø - 2015 ¹ÙµðÚ¸ìÑ ½æ¸Ó À̺¥Æ® 1 2,911 2015-06-15
94 È­Á¢¸ùÇÑÀÇ¿ø - ¸ð°ø°¢È­Áõ ÆÈ¶Ò EVENT 0 3,161 2015-06-15
93 ÀÚ¿¬°ú ÇÑÀÇ¿ø - ¿©¸§ ´ëºñ ÆÐÅ°Áö ÇÑ´Þ 24¸¸¿ø À̺¥Æ® 0 3,643 2015-06-15
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷